DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Type, Technology, End User and Country" report has been added to ResearchAndMarkets.com's offering.
The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 2,570.37 Mn in 2027 from US$ 878.28 in 2018. The market is estimated to grow with a CAGR of 12.8% from 2019-2027.
The key factors responsible for the growth of the market in Asia Pacific are rising burden of genetic diseases among infants, increasing fertility rates and developing healthcare scenario with rising awareness among populace regarding the benefits of prenatal testing.
On the other hand, use of digital microfluidics in newborn testing is likely to be a prevalent trend in the future years. Soaring birth rates among developing economies are responsible for fueling global baby boom. However, the rising birth rate also contributes to rising birth defects and infants suffering from several genetic diseases. According to a report published by Bill and Melinda Gates Foundation in 2018, there are almost 250 babies born every minute around the globe. Moreover, according to the Centers for Disease Control and Prevention, the fertility rates for Hispanic women was highest in 2017 among Hispanic women with 67.1 births per 1,000 women.
Asian countries such as India and China also have high fertility rates due to factors such as effects of religion, inadequate supply of family welfare services, poverty, and others. According to the World Bank in 2016, the fertility rates in India were reported to be 2.23 births per women as compared to 1.80 in the United States and 1.62 in China. Moreover, neighboring countries in India, such as Pakistan also has alarming rates of fertility.
In 2016, the birth rate in Pakistan was reported to be 3.48 births per woman as per the World Bank data. However, the birthrate in India have successfully reduced its high fertility rate, but still is high as compared to other developed nations. According to the United Nations (UN) report published on June 2019, the fertility rate has reduced to 2.1. Therefore, by 2050 additional 273 million people will be added to India's population. The increasing number of parturient women across the world are thus likely to create increasing demand for prenatal and newborn genetic tests across the globe leading to the growth of the market.
The Asia Pacific prenatal and newborn genetic testing market, based on the disease indication was segmented into cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria, recurrent pregnancy loss, and Antiphospholipid syndrome, and other diseases. In 2018, Down syndrome segment held the largest share of the market, by disease indication. The highest share of Down syndrome attributes to the high prevalence of this genetic abnormality among fetuses and availability of multiple tests for its screening and diagnostics. However, the cystic fibrosis segment is expected to grow at the fastest rate during the coming year.
Some of the major primary and secondary sources for prenatal and newborn genetic testing included in the report are Food & Drug Administration (FDA), Indian Institutes of Technology (IITs), International Trade Administration (ITA), Japan Society of Obstetrics and Gynecology (JSOG), Council of Scientific and Industrial Research (cSIR), Pakistan Down Syndrome Association (PDSA) and others.
Key Topics Covered
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Type
1.3.2 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Disease Indication
1.3.3 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Technology
1.3.4 Asia Pacific Prenatal and Newborn Genetic Testing Market - By End-user
1.3.5 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Country
2. Asia Pacific Prenatal And Newborn Genetic Testing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Prenatal And Newborn Genetic Testing- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific - PEST Analysis
5. Asia Pacific Prenatal And Newborn Genetic Testing Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Burden of Genetic Diseases in India
5.1.2 Increasing Fertility Rate
5.2 Key Market Restraints
5.2.1 Risks Associated with Prenatal Testing
5.3 Key Market Opportunities
5.3.1 Development of Policy for Treatment of Rare Diseases
5.4 Future Trends
5.4.1 Digital Microfluidics Poses a New Opportunity Area for the Newborn Screening Market
5.5 Impact Analysis
6. Prenatal And Newborn Genetic Testing Market - Asia Pacific Analysis
6.1 Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Forecasts And Analysis
6.2 Performance of Key Players
6.3 India Ultrasound Screening Market
7. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Type
7.1 Overview
7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Type 2018 & 2027 (%)
7.3 Diagnostic Market
7.4 Screening Market
8. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Disease Indication
8.1 Overview
8.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Disease Indication 2018 & 2027 (%)
8.3 Cystic Fibrosis
8.4 Sickle Cell Anemia
8.5 Down Syndrome
8.6 Phenylketonuria
8.7 Recurrent Pregnancy Loss
8.8 Antiphospholipid Syndrome (APS)
8.9 Other Diseases
9. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Technology
9.1 Overview
9.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Technology 2018 & 2027 (%)
9.4 Spectrophotometer
9.5 Polymerase Chain Reaction Market
9.6 Fluorescence in-situ Hybridization Market
9.7 Array Comparative Genomic Hybridization Market
9.8 Others Market
10. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - End User
10.1 Overview
10.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by End User 2018 & 2027 (%)
10.3 Hospitals & Clinics
10.4 Diagnostics Centers
10.5 Other End Users
11. Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 - Geographical Analysis
11.1 Asia Pacific Prenatal And Newborn Genetic Testing Market
11.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
12. Prenatal And Newborn Genetic Testing Market - Industry Landscape
12.1 Overview
12.2 Comparative Company Analysis
12.3 Growth Strategies Done by the Companies in the Market, (%)
12.4 Organic Developments
12.5 Inorganic Developments
13. Prenatal And Newborn Genetic Testing Market - Key Company Profiles
13.1 LifeCell
13.2 Quest Diagnostics Incorporated
13.3 Medgenome
13.4 Eurofins Scientific
13.5 Metropolis India
13.6 SRL Diagnostics
13.7 Sandor Lifesciences Pvt. Ltd.
13.8 PerkinElmer, Inc.
13.9 Natera, Inc.
13.10 Laboratory Corporation Of America Holdings (Sequenom)
13.11 Genes2Me L.L.P.
13.12 Illumina, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ol7fgi
